Skip to search.
 TSX Down 0.05% TSX Ventures Up 0.82%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
47.11 Down 0.87(1.81%) 10:30AM EDT - Nasdaq Real Time Price
Prev Close:47.98
Open:47.52
Bid:47.02 x 200
Ask:47.10 x 200
1y Target Est:48.08
Beta:1.96681
Next Earnings Date:N/A
Day's Range:46.88 - 47.94
52wk Range:26.02 - 49.66
Volume:140,847
Avg Vol (3m):869,157
Market Cap:6.60B
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENDown 1.81%6.60B
IMGNDown 2.74%247.30M
PFEDown 0.75%221.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.00
Quarterly EPS Est (Sep-16) :-0.30
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback